thiohydantoins and Stevens-Johnson-Syndrome

thiohydantoins has been researched along with Stevens-Johnson-Syndrome* in 4 studies

4 other study(ies) available for thiohydantoins and Stevens-Johnson-Syndrome

Article	Year
Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamide. Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:2 Topics: Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Stevens-Johnson Syndrome; Thiohydantoins	2023
Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis. The Journal of dermatology, 2022, Volume: 49, Issue:3 Topics: Humans; Plasmapheresis; Stevens-Johnson Syndrome; Thiohydantoins	2022
Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy. Acta dermato-venereologica, 2022, 05-24, Volume: 102 Topics: Etanercept; Humans; Steroids; Stevens-Johnson Syndrome; Thiohydantoins	2022
Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug. The Journal of dermatology, 2020, Volume: 47, Issue:10 Topics: Humans; Male; Pharmaceutical Preparations; Prostatic Neoplasms; Stevens-Johnson Syndrome; Thiohydantoins	2020